Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome.

Details

Serval ID
serval:BIB_375D7883DBA1
Type
Article: article from journal or magazin.
Collection
Publications
Title
Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome.
Journal
Kidney International
Author(s)
Harambat J., Fargue S., Acquaviva C., Gagnadoux M.F., Janssen F., Liutkus A., Mourani C., Macher M.A., Abramowicz D., Legendre C., Durrbach A., Tsimaratos M., Nivet H., Girardin E., Schott A.M., Rolland M.O., Cochat P.
ISSN
1523-1755[electronic], 0085-2538[linking]
Publication state
Published
Issued date
2010
Volume
77
Number
5
Pages
443-449
Language
english
Notes
Publication types: Journal Article
Abstract
We sought to ascertain the long-term outcome and genotype-phenotype correlations available for primary hyperoxaluria type 1 in a large retrospective cohort study. We examined the clinical history of 155 patients (129 families primarily from Western Europe, North Africa, or the Middle East) as well as the enzymatic or genetic diagnosis. The median age at first symptom was 4 years, and at diagnosis 7.7 years, at which time 43% had reached end-stage renal disease. Presentations included: (1) early nephrocalcinosis and infantile renal failure, (2) recurrent urolithiasis and progressive renal failure diagnosed during childhood, (3) late onset with occasional stone passage diagnosed in adulthood, (4) diagnosis occurring on post-transplantation recurrence, and (5) family screening. The cumulative patient survival was 95, 86, and 74% at ages 10, 30, and 50 years, respectively, with the cumulative renal survival of 81, 59, 41, and 10% at ages 10, 20, 30, and 50 years, respectively; 72 patients had undergone a total of 97 transplantations. Among the 136 patients with DNA analysis, the most common mutation was p.Gly170Arg (allelic frequency 21.5%), with a median age at end-stage renal disease of 47 years for homozygotes, 35 years for heterozygotes, and 21 years for other mutations. Our results underscore the severe prognosis of primary hyperoxaluria type 1 and the necessity for early diagnosis and treatment, as well as confirm a better prognosis of the p.Gly170Arg mutation.
Keywords
Amino Acid Substitution, Arginine/metabolism, Child, Child, Preschool, Cohort Studies, Genotype, Heterozygote, Homozygote, Humans, Hyperoxaluria, Primary/diagnosis, Hyperoxaluria, Primary/genetics, Infant, Kidney Failure, Chronic/genetics, Mutation, Phenotype, Prognosis, Retrospective Studies, Transaminases/genetics
Pubmed
Open Access
Yes
Create date
15/02/2011 13:09
Last modification date
20/08/2019 14:25
Usage data